Journal Information
Vol. 58. Issue 2.
Pages 100-105 (1 February 2003)
Share
Share
Download PDF
More article options
Vol. 58. Issue 2.
Pages 100-105 (1 February 2003)
Full text access
Incidencia de alergia a proteínas de leche de vaca en el primer año de vida y su repercusión en el consumo de hidrolizados
Iincidence of allergy to cows milk protein in the first year of life and its effect on consumption of hydrolyzed formulae
Visits
10980
M.aC. García Ara*, M.T.a Boyano Martínez, J.M. Â Díaz Penaa, F. Martín Muñoz, C. Pascual Marcos, G. García Sánchez, M. Martín Esteban
Servicio de Alergia. Hospital Infantil Universitario La Paz. Madrid. España
This item has received
Article information
objetivo

Cálculo de la incidencia de alergia a proteínas de lechede vaca (APLV) en el lactante y coste del tratamiento con hidrolizados de leche de vaca en la comunidad de Madrid

Pacientes y métodos

Lactantes con sospecha de APLV nacidos entre el 1 demarzo de 2000 y el 28 de febrero de 2001 en el Hospital LaPaz pertenecientes a las áreas que atiende el Hospital Infantil.Se les aplicó el algoritmo diagnóstico de APLV delservicio. Se realizó el cálculo teórico del consumo de hidrolizadosutilizados en el tratamiento de los APLV y seextrapoló a la comunidad de Madrid

Resultados

Nacidos vivos en el Hospital La Paz pertenecientes a lasáreas citadas: 5.356 niños. Consultaron por sospecha fundadade APLV: 185 niños. Se diagnosticaron como alérgicosa PLV a 101 (54 %). La incidencia calculada de APLV fue de:101/5.356: 1,9 %. Nacidos en la comunidad de Madrid enel mismo período: 57.078 niños. El número de posiblesAPLV en un año sería de 1.084. El cálculo aproximado deconsumo de hidrolizados en el primer año de vida porniño, supone un coste de 1.585,72 3. El gasto de hidrolizadosen los 1.084 alérgicos en la comunidad de Madrid seríade 1.718.922,9 3. El gasto de los 923 niños en los que sedescartó alergia supondría 1.463.621,8 3

Conclusiones

La incidencia de APLV en el primer año de vida en nuestromedio es de, al menos, 1,9 %. El diagnóstico correctopermite descartar APLV en casi la mitad de los casos, evitandosometer al lactante a dietas innecesarias y que suponenun elevado coste

Palabras clave:
Incidencia
Alergia a proteínas de leche de vaca
Tratamiento
Hidrolizados
objective

The aims of this study were to determine the incidenceof allergy to cows milk protein in infants and the cost oftreatment with hydrolyzed formulae in the AutonomousCommunity of Madrid.

Patients and method

Infants with suspected adverse reaction to cow’s milkprotein born between March 1, 2000 and February 28,2001 within the catchment area covered by the pediatricservices of Hospital La Paz were studied. The diagnosticalgorithm of allergy to cows milk protein of our departmentwas used. The theoretical consumption of hydrolyzedformulae in the treatment of allergic infants wascalculated and extrapolated to the Community of Madrid

Results

There were 5367 live births in the above-mentionedcatchment area. Adverse reaction to cows milk proteinwas suspected in 185 infants. Allergy to cows milk proteinwas confirmed in 101 (54 %). The incidence of allergy tocows milk protein was 101/5356 (1.9 %). In the same periodthere were 57 078 live births in the Autonomous Communityof Madrid. The number of infants that might be alleallergicin one year would be 1084. The cost of hydrolyzedformulae per infant and year would be 1,585.72 Euros.Thus, the cost of hydrolyzed formulae in the 1084 allergicinfants would be 1,718,922.9 Euros; in the 923 in whom allergywas ruled out, the cost would be 1,463,621.8 Euros

Conclusions

The incidence of allergy to cows milk protein in thefirst year of life is at least 1.9 %. The correct diagnosis allowsus to rule out allergy to cows milk protein in almost

Key words:
Incidence
Allergy to cows milk protein
Treatment
Hydrolyzed formulae
Full text is only aviable in PDF
Bibliografía
[1.]
International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC.
Lancet, 351 (1998), pp. 1225-1232
[2.]
J.B. Hourihane, T.P. Dean, J.O. Warner.
Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: Results of a questionnaire survey, skin prick testing, and food challenges.
BMJ, 313 (1996), pp. 518-521
[3.]
A. Dannaeus, M. Inganas.
A follow-up study of children with food allergy. Clinical course in relation to serum IgE and IgG antibody levels to milk, egg and fish.
Clin Allergy, 11 (1981), pp. 533-539
[4.]
M. Martín Esteban, C. Pascual Marcos, M.C. García Ara, J.A. Ojeda Casas.
Influencia de la lactancia en la aparición de alergia inmediata a proteínas de leche de vaca.
Rev Esp Alergol Immunol Clin, 1 (1986), pp. 63-67
[5.]
M.C. Garcia Ara, M.T. Boyano Martinez, J.M. Diaz Pena, F. Martin Muñoz, M. Reche Frutos, M. Martin Esteban.
Specific IgE levels in the diagnosis of inmediate hypersensitivity to cows milk protein in the infant.
J Allergy Clin Immunol, 107 (2001), pp. 185-190
[6.]
I. Jakobsson, T. Lindberg.
A prospective study of cow's milk protein intolerance in Swedish infants.
Acta Paediatr Scand, 68 (1979), pp. 853-859
[7.]
J.W. Gerrard, J.W. Mackenzie, N. Goluboff.
Cow's milk allergy: Prevalence and manifestations in an unselected series of newborns.
Acta Paediatr Scand, 234 (1973), pp. 3-21
[8.]
A. Host, S. Halken.
A prospective study of cow milk allergy in Danish infants during the first 3 years of life.
Allergy, 45 (1990), pp. 587-596
[9.]
K.M. Saarinen, K. Juntunen-Backman, A.L. Jarvenpaa, P. Kuitunen, L. Lope, M. Renlund.
Supplementary feeding in maternity hospitals and the risk of cow's milk allergy: A prospective study of 6209 infants.
J Allergy Clin Immunol, 104 (1999), pp. 457-461
[10.]
D. Altintas, S. Guneser, N. Evliyaoglu, B. Yüksel, A. Atict, M. Serbest.
A prospective study of cow's milk allergy in Turkish infants.
Acta Paediatr, 84 (1995), pp. 1320-1321
[11.]
J. Sanz Ortega, A. Martorell Aragonés, A. Michvila Gómez.
Estudio de la incidencia de alergia mediada por IgE frente a la proteína de la leche de vaca en el primer año de vida.
An Esp Pediatr, 545 (2001), pp. 36-39
[12.]
S.A. Bock, F.J. Atkins.
Patterms of fod hypersensitivity during xisteen years of double-blind, placebo-controlled food challenges.
J Pediatr, 117 (1990), pp. 561-567
[13.]
S.A. Bock, H.A. Sampson, F.J. Atkins, R.S. Zeiger, S. Lerher, M. Sachs.
Double-blind placebo controlled food challenge as an office procedure: A manual.
J Allergy Clin Immunol, 82 (1988), pp. 86-97
[14.]
H.A. Sampson.
Relations between food specific IgE concentrations and the risk of positive food challenges in children and adolescents.
J Allergy Clin Immunol, 100 (1997), pp. 444-451
[15.]
M.T. Boyano Martinez, M.C. Garcia Ara, J.M. Diaz Pena, F. Martin Muñoz, G. Garcia Sanchez, M. Martin Esteban.
Validity of specific IgE antibodies in children with egg allergy.
Clinical and Experimental Allergy, 31 (2001), pp. 1464-1469
[16.]
L. Businco, S. Dreborg, R. Einarsson, P.G. Giampietro, A. Host, K.M. Keller.
Hydrolysed cow's milk formulae. An ESPACI position paper.
Pediatr Allergy Immunol, 4 (1993), pp. 101-111
Copyright © 2003. Asociación Española de Pediatría
Download PDF
Idiomas
Anales de Pediatría (English Edition)
Article options
Tools